Navigation Links
New Treatment Combo Better Against Hepatitis C
Date:4/29/2009

at you are going to see is a mixture of antivirals and my own prediction is you won't see it with interferon and ribavirin," he said.

Schiff thinks these new medications will get more people to go for treatment, because there are fewer side effects and the treatment time is shorter.

In the United States, about 4 million people have HCV, Schiff said. "Most of those people haven't been diagnosed. Of the 1 million who have been diagnosed, maybe 400,000 to 500,000 have been treated, and about 50 percent have been cured," he said.

"If you have an all-oral, highly efficacious regimen with relatively few side effects, then these people who haven't been diagnosed but know they have risk factors are going to come forward, because when they are diagnosed, there is going to be treatment that has a high percentage of cure," Schiff said.

Around the world, 180 million people have HCV. HCV is the leading cause of cirrhosis and liver cancer, and the most common reason for liver transplantation in the United States. HCV is spread mostly by sharing needles.

More information

For more on hepatitis C, visit the U.S. National Institute of Diabetes and Digestive and Kidney Diseases.



SOURCES: John G. McHutchison, M.D., Duke University Medical Center, Durham, N.C.; Jean-Michel Pawlotsky, M.D., Ph.D., Henri Mondor Hospital, University of Paris, France; Eugene Schiff, M.D., chief, division of hepatology, University of Miami School of Medicine; April 30, 2009, New England Journal of Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. New Treatment Discovered for Restless Legs Syndrome Improves Sleep
2. Free Treatment for Breast Cancer Available in Pennsylvania
3. Zebrafish offer clues to treatments for motor neurone disease
4. New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes
5. Varicose Veins Pose Scary Health Risk; Sufferers Find Solace With Insurance-Covered Treatment at Renaissance Laser and Vein Institute
6. Study finds higher drug co-pays discourage patients from starting treatment
7. A Call to Action: NGOs Working in Blindness Prevention and Treatment Convene Special Forum to Address Gender and Eye Health
8. Turtle Island Oxygen Trust Sponsors Free Hyperbaric Treatments
9. Product Shifts are Occurring in the Renal Anemia and Bone and Mineral Metabolism Markets According to the Most Recent TreatmentTrends(R): US Nephrology Report from BioTrends Research Group
10. Different treatment options in chronic coronary artery disease
11. Wyeths CONBRIZA Approved in the European Union for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Treatment Combo Better Against Hepatitis C
New Treatment Combo Better Against Hepatitis C
(Date:11/22/2009)... The Onder Law Firm’s at...those or families of those who may have experience...blems after taking XOLAIR. , ... Onder Law Firm are among attorneys offering free...uch as heart attack and stroke. The attorneys of ...
(Date:11/22/2009)...the skin,s surface, bacteria are abundant, diverse...esearch at the University of California, San Diego...eria living on the skin surface trigger a pathway ... , "These germs are actually good for us," said ...nd pediatrics, chief of UCSD,s Division of Dermato...
(Date:11/22/2009)...ing ahead can help keep eating under control, expe...ews) -- The holiday season means you,ll be faced w... While some people simply give in and eat too much...But there are ways to navigate between overindulge...anager of Nutrition Consult Services at Brigham an...
(Date:11/22/2009)... Man & Machine post You Tu...rsus the competition , La...eyboard users interested in learning what a really...tune into “Really Cool Keyboard vs Washable ... The film demonstrates how the premium, Really Co...
(Date:11/21/2009)... , WASHINGTON, Nov. 21 /PRNewswire-USNewswire/...atement after the Senate voted to begin full debat...Logo: http://www.newscom.com/cgi-bin/prnh/2008051...r historic step on the road to enacting health ins...urdle, senators will now have an opportunity to de...
Breaking Medicine News(10 mins):Health News:The Attorneys of The Onder Law Firm Offers Free XOLAIR Case Review 2Health News:Surface bacteria maintain skin's healthy balance 2Health News:Go Healthy, Not Hungry for Holiday Eating 2Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2
...ctions during the first year of life are a marker ...arthritis later in life, according to new research...nual Congress of the European League Against Rheum...birthday had an increased likelihood of developing...
...sue of selling kidneys. , A regulated system of c...to the growing shortage of kidneys for transplanta... the University of Minnesota. , In many areas of...e annual death rate for suitable transplant candid...
...s, Inc., a,leader in orthopedic extremity implants...ves, William F. Warrender, Jr., John F. Walters an...eir extensive background and,experience will make ...He brings more than 25 years of sales, marketing a...
...in single nucleotide polymorphisms (SNPs) within t...n are shown to be associated with juvenile idiopat...wo independent cohorts presented today at EULAR 20...tic code), rs2104286, rs41295061 and rs11594656, w...
...HINGTON, June 13 A team of professionals,from Nat...rmany on Saturday,to work with the US Army,s Europ...eir current rehabilitation practices. They will al...n,services. The ERMC operates 15 ambulatory care c...
...to resolve remaining issues, TORONTO, June 13 /PR...PreMD Inc. (TSX: PMD; Amex: PME) today announced t...U.S. Food and Drug Administration (FDA) in an,effo...60 days PreMD and the FDA will work together to tr...
Other Medicine News:Health News:Early life infections increase the risk of rheumatoid arthritis and juvenile idiopathic arthritis 2Health News:What's wrong with selling kidneys? 2Health News:Three Industry Veterans Join Ascension Orthopedics 2Health News:Three Industry Veterans Join Ascension Orthopedics 3Health News:Specific mutations in the IL2RA gene associated with juvenile idiopathic arthritis 2Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 2Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 3Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 4Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 5Health News:PreMD Reports Further Positive Meetings with the FDA 2
(Date:11/20/2009)...a., Nov. 20 In response...ns why currently available medications designed to... ECRI Institute, an independent nonprofit organiza...nasteride for Prevention of Prostate Cancer for ...York Times article, " Drugs to Deter Some Cancers...
(Date:11/20/2009).... 20 Soligenix, Inc. (OT..., formerly known as DOR BioPharma, Inc., a late-st... has formed a consortium to develop thermostable t...cting vaccines. Soligenix received a $9.4 million ...nfectious Diseases (NIAID), a division of the Nati...
(Date:11/19/2009)... In response to an ever-increasing ... medicines, Operation Pangea II, involving 24 coun...ealth Organization,s International Medical Product...ght the dangers of buying medicines online. ,, ...es of arrests and the seizure of thousands of pote...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Chicago Hispanic Health Coalition Presents Third Annual Vive tu Vida 21 Get Up 21 Get Moving 21 28TM 29 Event 49009 1Chicago Hispanic Health Coalition Presents Third Annual Vive tu Vida 21 Get Up 21 Get Moving 21 28TM 29 Event 49009 2WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference 12644 1Celsis Outlines the Top Five Advantages of Cryo plateable Hepatocytes 12642 1Celsis Outlines the Top Five Advantages of Cryo plateable Hepatocytes 12642 2Celsis Outlines the Top Five Advantages of Cryo plateable Hepatocytes 12642 3Celsis Outlines the Top Five Advantages of Cryo plateable Hepatocytes 12642 4
...mpany,developing clinical stage treatments for can...y announced positive results from its Phase II,cli...e treatment of,advanced metastatic melanoma, at th...linical Oncology (ASCO) in Chicago, IL., Clinical...II trial was conducted at seven U.S.,clinical cent...
... HealthCore Presents Data on, Contributing Factors...t of Women with Breast Cancer and Reduc...oday,presented a study [Abstract No: 6593] compari... treatment guidelines for newly diagnosed breast,c...an Society of Clinical,Oncology (ASCO) in Chicago....
Other Medicine Technology:BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 3BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 4Study Finds Disparities in Breast Cancer Treatment Even Among Fully-Insured African-American and Caucasian Women 2Study Finds Disparities in Breast Cancer Treatment Even Among Fully-Insured African-American and Caucasian Women 3
Troutman-Barraquer Corneal Utility Forceps, Colibri Style - 0.5 mm
Catalano Corneal Scleral Forceps
Troutman-Barraquer Corneal Utility Forceps, Colibri Style
Colibri Forceps 0.12 mm
Medicine Products: